Sentiment-Signal
13,2
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Unternehmen & Branche
| Name | Entrada Therapeutics, Inc. |
|---|---|
| Ticker | TRDA |
| CIK | 0001689375 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 479,4 Mio. USD |
| Beta | -0,15 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 25,421,000 | -143,750,000 | -3.47 | 377,378,000 | 306,133,000 |
| 2025-09-30 | 10-Q | 1,614,000 | -44,134,000 | -1.06 | 412,898,000 | 340,716,000 |
| 2025-06-30 | 10-Q | 1,950,000 | -43,103,000 | -1.04 | 448,783,000 | 379,505,000 |
| 2025-03-31 | 10-Q | 20,558,000 | -17,349,000 | -0.42 | 486,479,000 | 417,260,000 |
| 2024-12-31 | 10-K | 210,782,000 | 65,626,000 | 1.68 | 526,321,000 | 428,678,000 |
| 2024-09-30 | 10-Q | 19,570,000 | -14,032,000 | -0.35 | 554,590,000 | 422,447,000 |
| 2024-06-30 | 10-Q | 94,694,000 | 55,031,000 | 1.55 | 581,963,000 | 429,925,000 |
| 2024-03-31 | 10-Q | 59,120,000 | 23,496,000 | 0.68 | 510,844,000 | 269,367,000 |
| 2023-12-31 | 10-K | 129,013,000 | -6,685,000 | -0.20 | 469,192,000 | 242,360,000 |
| 2023-09-30 | 10-Q | 43,735,000 | 35,461,000 | 1.02 | 485,033,000 | 246,663,000 |
| 2023-06-30 | 10-Q | 18,170,000 | -25,928,000 | -0.78 | 493,983,000 | 206,908,000 |
| 2023-03-31 | 10-Q | 25,260,000 | -6,674,000 | -0.21 | 475,569,000 | 229,612,000 |
| 2022-12-31 | 10-K | -94,616,000 | -3.02 | 252,056,000 | 212,554,000 | |
| 2022-09-30 | 10-Q | 0 | -25,137,000 | -0.80 | 274,463,000 | 233,220,000 |
| 2022-06-30 | 10-Q | 0 | -23,179,000 | -0.74 | 295,917,000 | 256,039,000 |
| 2022-03-31 | 10-Q | 0 | -21,671,000 | -0.69 | 316,702,000 | 277,391,000 |
| 2021-12-31 | 10-K | -51,158,000 | -8.16 | 305,833,000 | 298,718,000 | |
| 2021-09-30 | 10-Q | -14,430,000 | -9.78 | 132,395,000 | -72,591,000 | |
| 2021-06-30 | 10-Q | -9,901,000 | -7.56 | -59,014,000 | ||
| 2021-03-31 | 10-Q | -8,380,000 | -6.67 | -49,669,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-01 | WENTWORTH KORY JAMES | Officer, Chief Financial Officer | Open Market Sale | -2,500 | 12.95 | -32,375.00 | -15,6% | |
| 2026-03-10 | WENTWORTH KORY JAMES | Officer, Chief Financial Officer | Open Market Sale | -11,388 | 13.02 | -148,215.96 | -71,6% | |
| 2026-03-10 | Dowden Nathan J | Officer, President & COO | Open Market Sale | -11,894 | 13.05 | -155,188.15 | -74,9% | |
| 2026-03-09 | WENTWORTH KORY JAMES | Officer, Chief Financial Officer | Open Market Sale | -5,089 | 13.00 | -66,162.60 | -32,0% | |
| 2026-03-09 | Dowden Nathan J | Officer, President & COO | Open Market Sale | -3,116 | 13.02 | -40,582.78 | -19,6% | |
| 2026-03-04 | WENTWORTH KORY JAMES | Officer, Chief Financial Officer | Open Market Sale | -7,988 | 12.25 | -97,892.14 | -47,3% | |
| 2025-11-21 | WENTWORTH KORY JAMES | Officer, Chief Financial Officer | Open Market Sale | -8,910 | 9.98 | -88,931.60 | -42,9% | |
| 2025-11-20 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 13,386 | 9.07 | 121,394.96 | +58,6% | |
| 2025-11-20 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 13,082 | 9.07 | 118,690.37 | +57,3% | |
| 2025-11-20 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 1,213 | 9.07 | 11,000.45 | +5,3% | |
| 2025-11-20 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 1,186 | 9.07 | 10,760.34 | +5,2% | |
| 2025-11-14 | 5AM Ventures V, L.P. | 10% Owner | Open Market Sale | -200,000 | 8.80 | -1,760,000.00 | -850,0% | |
| 2025-11-14 | PARMAR KUSH | Director, 10% Owner | Open Market Sale | -200,000 | 8.80 | -1,760,000.00 | -850,0% | |
| 2025-11-12 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 1,040 | 7.95 | 8,272.89 | +4,0% | |
| 2025-11-12 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 7,321 | 7.73 | 56,602.31 | +27,3% | |
| 2025-11-12 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 11,494 | 7.95 | 91,431.32 | +44,2% | |
| 2025-11-12 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 80,881 | 7.73 | 625,331.45 | +302,0% | |
| 2025-11-11 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 1,059 | 7.39 | 7,826.96 | +3,8% | |
| 2025-11-11 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 11,701 | 7.39 | 86,480.92 | +41,8% | |
| 2025-11-11 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 30,879 | 7.54 | 232,812.22 | +112,4% | |
| 2025-11-11 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 2,795 | 7.54 | 21,072.90 | +10,2% | |
| 2025-11-10 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 2,296 | 7.21 | 16,563.11 | +8,0% | |
| 2025-11-10 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 25,364 | 7.21 | 182,973.36 | +88,4% | |
| 2025-11-10 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 2,947 | 7.22 | 21,290.31 | +10,3% | |
| 2025-11-10 | BAKER BROS. ADVISORS LP | 10% Owner | Open Market Purchase | 267 | 7.22 | 1,928.91 | +0,9% | |
| 2025-07-09 | 5AM Ventures V, L.P. | 10% Owner | Open Market Sale | -20,065 | 7.50 | -150,527.63 | -72,7% | |
| 2025-07-09 | 5AM Ventures V, L.P. | 10% Owner | Open Market Sale | -6,935 | 7.50 | -52,026.37 | -25,1% | |
| 2025-07-01 | 5AM Ventures V, L.P. | 10% Owner | Open Market Sale | -18,578 | 7.12 | -132,323.66 | -63,9% | |
| 2025-07-01 | 5AM Ventures V, L.P. | 10% Owner | Open Market Sale | -6,422 | 7.12 | -45,741.34 | -22,1% | |
| 2025-06-30 | 5AM Ventures V, L.P. | 10% Owner | Open Market Sale | -18,578 | 6.81 | -126,566.34 | -61,1% | |
| 2025-06-30 | 5AM Ventures V, L.P. | 10% Owner | Open Market Sale | -6,422 | 6.81 | -43,751.16 | -21,1% | |
| 2025-06-27 | 5AM Ventures V, L.P. | 10% Owner | Open Market Sale | -55,735 | 6.91 | -385,128.85 | -186,0% | |
| 2025-06-27 | 5AM Ventures V, L.P. | 10% Owner | Open Market Sale | -19,265 | 6.91 | -133,121.15 | -64,3% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.